Neonatal Bubble CPAP (Hudson™ interface) Setup for the F&P 950™ System

In 2015, 2.7 million babies died in their first 28 days of life, and 98% of these deaths occurred in developing countries. Adara, and our amazing partners at the University of Washington and PATH have been innovating to develop a safe and affordable treatment for respiratory distress syndrome—the most common cause of disease and death for babies born before 34 weeks gestation. We want to bring this device to global scale to save hundreds of thousands of newborn lives each and every year. Watch t